1
Kevin J Brodbeck, Ann T Gaynor Duarte, Theodore Tao Ian Shen: Gel composition and methods. Alza Corporation, John A Dhuey, Steven F Stone, October 10, 2000: US06130200 (112 worldwide citation)

Methods and compositions for systemically or locally administering by implantation a beneficial agent to a subject are described, and include, for example, compositions having burst indices of 8 or less for systemic applications and systems releasing 10% or less of the total dose of beneficial agent ...


2
Kevin J Brodbeck, Ann T Gaynor Duarte, Theodore Tao Ian Shen: Gel composition and methods. Alza Corporation, Vandana Date, January 6, 2004: US06673767 (67 worldwide citation)

Methods and compositions for systemically or locally administering by implantation a beneficial agent to a subject are described, and include, for example, compositions having burst indices of


3
Kevin J Brodbeck, Ann T Gaynor Duarte, Theodore Tao Ian Shen: Gel composition and methods. Alza Corporation, Vandana Date, October 22, 2002: US06468961 (51 worldwide citation)

Methods and compositions for systemically or locally administering by implantation a beneficial agent to a subject are described, and include, for example, compositions having burst indices of 8 or less for systemic applications and systems releasing 10% or less of the total dose of beneficial agent ...


4
Gary L Hansen, Richard E Trapp, Robert B Clay: Phosphorescent toy gel composition and methods of manufacture. Glow Tec, Workman Nydegger & Jensen, May 3, 1994: US05308546 (13 worldwide citation)

The phosphorescent toy gel composition is produced by suspending phosphorescent particles in an aqueous solution, thickened with guar gum and crosslinked by a borate compound. The method for manufacturing the phosphorescent gel composition comprises, in one aspect, the steps of providing a water-bas ...


5
Irina Travkina, Lisa Lamberty, Harold Pahlck: Gel composition and methods of use. Avon Products, Ohlandt Greeley Ruggiero & Perle, January 6, 2004: US06673863 (3 worldwide citation)

There is provided a gel composition having a silica powder and a non-volatile compound. The silica powder particles are spherical and porous. The silica powder has a specific gravity about 0.09 to about 0.6, and is present in an amount about 10 wt % to about 50 wt %. The non-volatile compound is pre ...


6
Travkina Irina, Lamberty Lisa, Pahlck Harold: Gel composition and methods of use. Avon Prod, October 13, 2004: EP1465486-A1 (1 worldwide citation)

There is provided a gel composition having a silica powder and a non-volatile compound. The silica powder particles are spherical and porous. The silica powder has a specific gravity about 0.09 to about 0.6, and is present in an amount about 10 wt % to about 50 wt %. The non-volatile compound is pre ...


7
Charles D Ebert, Steven W Sanders: Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy. Watson Laboratories, Florek & Endres PLLC, August 14, 2012: US08241662

The present invention provides compositions and methods for administering oxybutynin while minimizing the incidence and or severity of adverse drug experiences associated with oxybutynin therapy. In one aspect, these compositions and methods provide a lower plasma concentration of oxybutynin metabol ...


8
Lauren Oshry, Elias Reichel: Aqueous gel composition and methods of use. ELLE PHARMACEUTICAL, Wood Phillips Katz Clark & Mortimer, November 14, 2017: US09814675

The present invention is directed to an aqueous gel composition containing a local anesthetic, a lubricating agent, and a preservative and methods of treating vaginal pain, such as dyspareunia by topically administering said composition.


9
Brodbeck Kevin J, Gaynor Duarte Ann T, Shen Theodore T: Compositions a base de gel et procedes connexes, Gel composition and methods. Alza Corporation, Durect Corporation, Smart & Biggar, February 8, 2011: CA2275525

Methods and compositions for systemically or locally administering by implantation a beneficial agent to a subject are described, and include, for example, compositions having burst indices of 8 or less for systemic applications and systems releasing 10 % or less of the total dose of beneficial agen ...


10